LataMed AI is trading 10.47% up at $0.42, with no new company-specific catalyst identified for September 14, 2026.
- The latest reported announcement was the September 9 cooperation agreement with Venezuela’s science and health ministries concerning planned healthcare-technology deployment in La Guaira, making it stale for explaining this move.
- Broader markets are declining, so the advance is not clearly explained by market direction.